Main menu button

Nyheter

Equity research Immunovia Q4 2025: Targeting Medicare sub-mission by mid-2026
25 feb 2026
Equity research Immunovia Q4 2025: Targeting Medicare sub-mission by mid-2026
Analysmaterial Immunovia
Equity research Immunovia Q4 2025: First impression - Modest Q4 sales, targeting Medicare submission by mid-2026
24 feb 2026
Equity research Immunovia Q4 2025: First impression - Modest Q4 sales, targeting Medicare submission by mid-2026
Analysmaterial Immunovia
Equity research Immunovia, Q3 2025: US reimbursement in focus
27 nov 2025
Equity research Immunovia, Q3 2025: US reimbursement in focus
Analysmaterial Immunovia
Equity research Immunovia: First impression, Q3 2025 - Successful rights issue to fuel launch and reimbursement progress
26 nov 2025
Equity research Immunovia: First impression, Q3 2025 - Successful rights issue to fuel launch and reimbursement progress
Analysmaterial Immunovia
Equity research Immunovia: PancreaSure launch in the US is underway
26 sep 2025
Equity research Immunovia: PancreaSure launch in the US is underway
Analysmaterial Immunovia
Equity research Immunovia: Eventful Q2 and rights issue to support PancreaSure launch
28 aug 2025
Equity research Immunovia: Eventful Q2 and rights issue to support PancreaSure launch
Analysmaterial Immunovia
Equity research Immunovia: PancreaSure test achieves CPT code assignment
02 jul 2025
Equity research Immunovia: PancreaSure test achieves CPT code assignment
Analysmaterial Immunovia
Equity research Immunovia: New study and FDA choose not to appeal LDT ruling
04 jun 2025
Equity research Immunovia: New study and FDA choose not to appeal LDT ruling
Analysmaterial Immunovia
Equity research Immunovia: All eyes on securing the launch of PancreaSure
15 maj 2025
Equity research Immunovia: All eyes on securing the launch of PancreaSure
Analysmaterial Immunovia
Equity Research Immunovia: Regulatory tailwind in the USA following ruling against the FDA
01 apr 2025
Equity Research Immunovia: Regulatory tailwind in the USA following ruling against the FDA
Analysmaterial Immunovia
Equity Research Immunovia: Second clinical validation of next-generation test
19 mar 2025
Equity Research Immunovia: Second clinical validation of next-generation test
Analysmaterial Immunovia
Equity Research Immunovia: Making headway with new cancer screening test
26 feb 2025
Equity Research Immunovia: Making headway with new cancer screening test
Analysmaterial Immunovia
Investment Case Immunovia: Promising clinical data and incoming triggers
11 dec 2024
Investment Case Immunovia: Promising clinical data and incoming triggers
Analysmaterial Immunovia